Long-term Effects of Imiquimod and Diclofenac in Actinic Keratoses (LEIDA 2)

Clinical trial NCT01453179 · COMPLETED

Trial details

NCT number: NCT01453179
Sponsor: MEDA Pharma GmbH & Co. KG
Status: COMPLETED
Phase: Phase 4
Study type: INTERVENTIONAL

Actinic Keratosis

Start date: 2011-10-01
Primary completion: 2015-03-01
Enrollment: 221

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.